
Colgate-Palmolive (CL) Stock Forecast & Price Target
Colgate-Palmolive (CL) Analyst Ratings
Bulls say
Colgate-Palmolive is a well-established company with a strong position in the household and personal care industry. With a strong history of over 200 years, the company has shown its ability to adapt and innovate in a rapidly changing market. Its diverse product portfolio, particularly its leading oral care and pet food brands, provides a solid foundation for growth in emerging markets, where it has a significant presence. While short-term volatility remains a concern, the company's locked-in costs, cost-saving initiatives, and sustainable practices bode well for its long-term growth potential. With an expected +2-3% organic sales growth and +6-7% EPS growth in 2026-28, we maintain a positive outlook on the stock, with a target of $92 (~22.0x our 2027E EPS of $4.15).
Bears say
Colgate-Palmolive is a well-established company with strong global reach in the household and personal care industry. However, recent macro pressures, volatility in emerging market currencies, and increased competitive activity in its core markets could hinder its target organic sales growth of +3-5%. Additionally, there are risks related to volatility in input costs and potential recessionary pressures, which could impact profitability. While the company has a consistent track record of delivering against its targets, it may face challenges in achieving its long-term goals due to these external factors.
This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.
Colgate-Palmolive (CL) Analyst Forecast & Price Prediction
Start investing in Colgate-Palmolive (CL)
Order type
Buy in
Order amount
Est. shares
0 shares